Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · IEX Real-Time Price · USD
2.34
-0.03 (-1.27%)
At close: Aug 12, 2022 4:00 PM
2.42
+0.08 (3.42%)
After-hours:
Aug 12, 2022 6:54 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Selling, General & Admin
|
29.52 | 17.59 | 8.95 | 2.03 | 1.27 |
| Research & Development
|
60.8 | 61.31 | 30.21 | 10.09 | 9.1 |
| Other Operating Expenses
|
0.25 | 0 | 0 | 0 | 0 |
| Operating Expenses
|
90.57 | 78.89 | 39.17 | 12.12 | 10.37 |
| Operating Income
|
-90.57 | -78.89 | -39.17 | -12.12 | -10.37 |
| Interest Expense / Income
|
0 | 0 | 0 | 0.96 | 1.64 |
| Other Expense / Income
|
-0.62 | -2.04 | -2.19 | -0.6 | 0.22 |
| Pretax Income
|
-89.95 | -76.85 | -36.98 | -12.48 | -12.24 |
| Net Income
|
-89.95 | -76.85 | -36.98 | -12.48 | -12.24 |
| Net Income Common
|
-89.95 | -76.85 | -36.98 | -12.48 | -12.24 |
| Shares Outstanding (Basic)
|
30 | 29 | 19 | 3 | 3 |
| Shares Outstanding (Diluted)
|
30 | 29 | 19 | 3 | 3 |
| Shares Change
|
1.86% | 53.30% | 466.06% | 1.79% | - |
| EPS (Basic)
|
-3.03 | -2.63 | -1.94 | -3.71 | -3.70 |
| EPS (Diluted)
|
-3.03 | -2.63 | -1.94 | -3.71 | -3.70 |
| Free Cash Flow Per Share
|
-2.12 | -1.74 | -1.75 | -3.54 | -3.00 |
| EBITDA
|
-89.6 | -76.52 | -36.79 | -11.47 | -10.55 |
| Depreciation & Amortization
|
0.34 | 0.33 | 0.19 | 0.05 | 0.05 |
| EBIT
|
-89.95 | -76.85 | -36.98 | -11.52 | -10.59 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).